Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

The Corporate Reputation of Pharma Industry - The Patient Perspective in 2015 - Europe Edition - Research and Markets

Research and Markets
Posted on: 04 Nov 16

Research and Markets has announced the addition of the "The Corporate Reputation of Pharma Industry - The Patient Perspective in 2015 - Europe Edition" report to their offering.

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 797 patient groups based in the Europe (Western and Eastern) in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the European pharma industry during 2015, as well as the performance of 45 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous year.

The report also offers, as case studies, survey responses from five companies, AbbVie Europe, Eisai, Janssen EMEA, Sanofi and Teva. These companies explain what they are doing on the subject of global patient centricity, and comment about their relationships with patient groups.

Company Background Information

- Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.

- The profiled company's main treatment subject areas (and areas of R&D).

- A mission statement from the profiled company.

How the Company has Performed at Six Indicators of Corporate Reputation

- The profiled company's performance at the six indicators of corporate reputation in 2015, according to the patient groups in Europe familiar with the company.

- The profiled company's performance at the six indicators of corporate reputation, according to the patient groups in Europe that have worked with the company.

- How the profiled company performed in Europe for different therapy areas, compared with the company's averages in Europe across all therapy areas in 2015.

- How the profiled company performed in Europe for different countries/regions, compared with the company's averages in Europe in 2015.

Companies Mentioned

  • AbbVie
  • Actavis
  • Amgen
  • Astellas Pharma
  • AstraZeneca
  • Baxalta
  • Bayer
  • Celgene
  • Chiesi Farmaceutici
  • Eisai
  • Eli Lilly (Lilly)
  • Ferring
  • Grünenthal
  • GSK
  • Menarini
  • Merck & Co
  • Merck KGaA
  • Mylan
  • Novartis
  • Novo Nordisk
  • Octapharma
  • Otsuka
  • Pfizer
  • Roche
  • Sandoz
  • Shire
  • Stada Arzneimittel
  • Takeda
  • Teva
  • UCB
  • ViiV Healthcare

For more information about this report visit http://www.researchandmarkets.com/research/lpjmv2/the_corporate

View source version on businesswire.com: http://www.businesswire.com/news/home/20161104005334/en/

Business Wire
www.businesswire.com

Last updated on: 04/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.